DMRA compared with JBIO: revenue, margins and what each company keeps, and the suppliers and customers both name

DMRADamora Therapeutics, Inc.

Mkt capRevenueRevenue

JBIOJade Biosciences, Inc.

Mkt capRevenueRevenue

Compare

DMRADamora Therapeutics, Inc.

JBIOJade Biosciences, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

DMRA

No earnings history for DMRA.

JBIO

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±18.9%▼−1.05%×0.06

May 8 '26±24.6%▲+6.56%×0.27

Q1 FY26±29.2%▲+1.22%×0.04

Jan 5 '26±26.0%▼−7.34%×0.28

= impliedDMRA realized, solidJBIO realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

DMRADamora Therapeutics, Inc.

21.50▼−2.30%· post 21.50

Mkt cap$1.3B

JBIOJade Biosciences, Inc.

14.07▼−1.19%· post 14.07

ClosedOct 30 '26

Mkt cap$894.2M

Compare

ClosedOct 30 '26

DMRADamora Therapeutics, Inc.

JBIOJade Biosciences, Inc.

21.50▼−2.30%post 21.50

Price

14.07▼−1.19%post 14.07

$1.3B

Mkt cap

$894.2M

DMRA21.50▼−2.30%vsJBIO14.07▼−1.19%ClosedOct 30 '26